Incyte Corp (INCY) stock
INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3088% above fair value
$117.80−1.29 (-1.08%)
Close on Nov 18, 2026Market cap $24.01BP/E 62.7Yield –
Incyte revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Incyte's revenue for the twelve months ending Sep 30, 2026 was $6.01B, up 24.9% year over year. For fiscal 2025 it was $5.14B, up 21.2% from the year before. Over ten years it grew 21.2% a year on average. The highest annual figure on record is $5.14B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.14B | +21.2% |
| FY2024 | Dec 31, 2024 | $4.24B | +14.8% |
| FY2023 | Dec 31, 2023 | $3.70B | +8.9% |
| FY2022 | Dec 31, 2022 | $3.39B | +13.7% |
| FY2021 | Dec 31, 2021 | $2.99B | +12.0% |
| FY2020 | Dec 31, 2020 | $2.67B | +23.5% |
| FY2019 | Dec 31, 2019 | $2.16B | +14.7% |
| FY2018 | Dec 31, 2018 | $1.88B | +22.5% |
| FY2017 | Dec 31, 2017 | $1.54B | +38.9% |
| FY2016 | Dec 31, 2016 | $1.11B | +46.7% |
| FY2015 | Dec 31, 2015 | $753.75M | +47.4% |
| FY2014 | Dec 31, 2014 | $511.50M | +44.1% |
| FY2013 | Dec 31, 2013 | $354.95M | +19.5% |
| FY2012 | Dec 31, 2012 | $297.06M | +214.5% |
| FY2011 | Dec 31, 2011 | $94.46M | -44.4% |
| FY2010 | Dec 31, 2010 | $169.88M | +1733.5% |
| FY2009 | Dec 31, 2009 | $9.27M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.56B | +14.0% |
| Q2 FY2026 | Jun 30, 2026 | $1.67B | +37.7% |
| Q1 FY2026 | Mar 31, 2026 | $1.27B | +20.9% |
| Q4 FY2025 | Dec 31, 2025 | $1.51B | +27.8% |
| Q3 FY2025 | Sep 30, 2025 | $1.37B | +20.0% |
| Q2 FY2025 | Jun 30, 2025 | $1.22B | +16.5% |
| Q1 FY2025 | Mar 31, 2025 | $1.05B | +19.5% |
| Q4 FY2024 | Dec 31, 2024 | $1.18B | +16.3% |
| Q3 FY2024 | Sep 30, 2024 | $1.14B | +23.8% |
| Q2 FY2024 | Jun 30, 2024 | $1.04B | +9.3% |
| Q1 FY2024 | Mar 31, 2024 | $880.89M | +8.9% |
| Q4 FY2023 | Dec 31, 2023 | $1.01B | +9.3% |
| Q3 FY2023 | Sep 30, 2023 | $919.03M | +11.6% |
| Q2 FY2023 | Jun 30, 2023 | $954.61M | +4.7% |
| Q1 FY2023 | Mar 31, 2023 | $808.67M | +10.3% |
| Q4 FY2022 | Dec 31, 2022 | $926.70M | +7.4% |
| Q3 FY2022 | Sep 30, 2022 | $823.30M | +1.3% |
| Q2 FY2022 | Jun 30, 2022 | $911.40M | +29.1% |
| Q1 FY2022 | Mar 31, 2022 | $733.24M | +21.3% |
| Q4 FY2021 | Dec 31, 2021 | $862.85M | +9.3% |
| Q3 FY2021 | Sep 30, 2021 | $812.99M | +31.0% |
| Q2 FY2021 | Jun 30, 2021 | $705.71M | +2.6% |
| Q1 FY2021 | Mar 31, 2021 | $604.72M | +6.4% |
| Q4 FY2020 | Dec 31, 2020 | $789.51M | +36.3% |
| Q3 FY2020 | Sep 30, 2020 | $620.64M | +12.5% |
| Q2 FY2020 | Jun 30, 2020 | $688.04M | +29.8% |
| Q1 FY2020 | Mar 31, 2020 | $568.51M | +14.2% |
| Q4 FY2019 | Dec 31, 2019 | $579.39M | +9.6% |
| Q3 FY2019 | Sep 30, 2019 | $551.58M | +22.7% |
| Q2 FY2019 | Jun 30, 2019 | $529.93M | +1.6% |
| Q1 FY2019 | Mar 31, 2019 | $497.86M | +30.2% |
| Q4 FY2018 | Dec 31, 2018 | $528.40M | +19.0% |
| Q3 FY2018 | Sep 30, 2018 | $449.68M | +17.9% |
| Q2 FY2018 | Jun 30, 2018 | $521.52M | +59.8% |
| Q1 FY2018 | Mar 31, 2018 | $382.28M | -0.5% |
| Q4 FY2017 | Dec 31, 2017 | $444.16M | +36.0% |
| Q3 FY2017 | Sep 30, 2017 | $381.53M | – |
| Q2 FY2017 | Jun 30, 2017 | $326.44M | – |
| Q1 FY2017 | Mar 31, 2017 | $384.08M | – |
| Q4 FY2016 | Dec 31, 2016 | $326.50M | – |
See a number that looks wrong?